封面
市场调查报告书
商品编码
1449600

肠外营养市场:依营养类型、依病患类型、依应用、依通路、按地区

Parenteral Nutrition Market, By Nutrition Type, By Patient Type, By Application, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 224 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球肠外营养市场价值为45.487亿美元,预计2031年将达72.51亿美元,2024年至2031年复合年增长率为6%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 45.487 亿美元
实际资料 2019-2023 预测期 2024-2031
预测期间 2023/2024 至 2030/2031 年复合年增长率: 6.00% 2030/2031 年预测值 72.51亿美元
图 1. 2024 年按地区分類的肠外营养全球市场占有率(%)
肠外营养市场-IMG1

肠外营养(通常称为全肠外营养)是静脉注射)的特殊型态食物的医学术语。治疗的目标是改善或预防营养不良。肠外营养提供液体营养素,如碳水化合物、蛋白质、脂质、维生素、矿物质和电解质。有些人使用肠外营养,透过在胃或小肠中放置一根管子来提供营养(经肠营养);其他人则单独使用肠外营养。肠外营养适用于消化器官系统无法吸收或耐受足够口服用餐的人。在医院外使用肠外营养时,称为家庭肠外营养。家庭肠外营养的使用可能需要数週至数月,在某些情况下可能需要终生。导管感染是肠外营养常见且严重的併发症。肠外营养的其他潜在短期併发症包括血栓、液体和矿物质失衡以及血糖代谢问题。

市场动态:

近年来,由于导致营养不良的慢性疾病盛行率不断上升,全球肠外营养市场出现了显着增长。当口服或肠内途径不可行时,肠外营养涉及透过静脉导管将营养素直接输送到血液中。肠外营养广泛应用于治疗患有癌症、胃肠道疾病、肝病和其他慢性疾病的营养不良患者。此外,由于消化器官系统较弱而更容易营养不良的老年人数量不断增加,也导致对肠外製剂的需求增加。不同的市场参与企业正在努力开发创新的肠外营养解决方案,以满足这些病患小组的治疗需求。然而,与肠外营养相关的高成本对广泛普及提出了重大挑战。

本研究的主要特点

  • 本报告详细分析了全球肠外营养市场,并提供了以2023年为基准年的预测期(2024-2031)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了各个细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数,介绍了全球肠外营养市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球肠外营养市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过分析全球肠外营养市场时所使用的各种策略矩阵来促进决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 主要市场相关人员加强合作
    • 缺乏对保健、用餐和适当营养的认识
    • 增强型肠外营养解决方案的出现
  • 主要亮点
  • 监管场景
  • 市场趋势
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 流行病学
  • 主要市场参与者的新投资
  • 价格分析
  • 合併、收购和合作

第四章全球肠外营养市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章全球肠外营养市场,依营养类型,2019-2031

  • 碳水化合物
  • 脂肪乳剂
  • 维生素和微量矿物质
  • 蛋白质
  • 其他(胺基酸等)

第六章全球肠外营养市场,依病患类型,2019-2031

  • 婴儿
  • 成人
  • 对于老年人

第七章 全球肠外营养市场,依应用分类,2019-2031

  • 糖尿病
  • 肾衰竭
  • 肌少症
  • 癌症
  • 其他(消化系统疾病、METABOLIC INC.症候群等)

第8章全球肠外营养市场,依通路,2019-2031

  • 医院药房
  • 零售药房
  • 网路药房

第9章全球肠外营养市场,依地区,2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 欧洲其他地区
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争格局

  • 公司简介
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA

第11章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI4804

The global parenteral nutrition market was valued US$ 4,548.7 Mn in 2023 and is expected to reach US$ 7,251 Mn by 2031 growing at a compound annual growth rate (CAGR) of 6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 4,548.7 Mn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 6.00% 2030/2031 Value Projection: US$ 7,251 Mn
Figure 1. Global Parenteral Nutrition Market Share (%), By Region, 2024
Parenteral Nutrition Market - IMG1

Parenteral nutrition, often called total parenteral nutrition, is the medical term for infusing a specialized form of food through a vein (intravenously). The goal of the treatment is to correct or prevent malnutrition. Parenteral nutrition provides liquid nutrients, including carbohydrates, proteins, fats, vitamins, minerals and electrolytes. Some people use parenteral nutrition to supplement feeding through a tube placed into the stomach or small bowel (enteral nutrition), and others use it by itself. People whose digestive systems either can't absorb or can't tolerate adequate food eaten by mouth use parenteral nutrition. When used outside the hospital, intravenous feeding is called home parenteral nutrition. Using home parenteral nutrition may be necessary for weeks or months, or in some cases for life. Catheter infection is a common and serious complication of parenteral nutrition. Other potential short-term complications of parenteral nutrition include blood clots, fluid and mineral imbalances, and problems with blood sugar metabolism.

Market Dynamics:

The global parenteral nutrition market has been witnessing significant growth in the recent past owing to the rising prevalence of chronic diseases inducing malnutrition. Parenteral nutrition entails delivering nutrients directly into the bloodstream through an intravenous catheter when oral or enteral routes are not feasible. It finds wide application in treating malnourished patients suffering from cancer, gastrointestinal disorders, liver diseases, and other chronic conditions. Furthermore, the growing geriatric population who are more susceptible to malnutrition due to weak digestive system has also contributed to the rising demand for parenteral formulations. Various market players are engaged in developing innovative parenteral nutrition solutions to meet the treatment demands of such patient groups. However, high costs associated with parenteral feeding remains a major challenge for widespread adoption.

Key features of the study:

  • This report provides an in-depth analysis of the global parenteral nutrition market and provides market size (US$ Mn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global parenteral nutrition market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include global parenteral nutrition market include AbbVie Inc., Danone, Fresenius Kabi AG, GENTAG, Inc., GSK plc., Nestle SA, Nutricia, Sun Pharmaceutical Industries Ltd, Pfizer Inc., Sanofi, Otsuka Holdings Co., Ltd., and Otsuka Holdings Co., Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global parenteral nutrition market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global parenteral nutrition market.

Detailed Segmentation:

  • Global Parenteral Nutrition Market, By Nutrition Type
    • Carbohydrates
    • Lipid Emulsion
    • Vitamins and Trace Minerals
    • Proteins
    • Others (Amino acids, etc.)
  • Global Parenteral Nutrition Market, By Patient Type
    • Infants
    • Adults
    • Geriatric
  • Global Parenteral Nutrition Market, By Application
    • Diabetes
    • Renal Failures
    • Obesity
    • Sarcopenia
    • Cancer
    • Others (Digestive disorders, Metabolic Syndromes, etc.)
  • Global Parenteral Nutrition Market, By Distribution Channel
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Parenteral Nutrition Market, By Region
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Top Companies in the Global Parenteral Nutrition Market:
    • AbbVie Inc.
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Nutrition Type
    • Market Snippet, By Patient Type
    • Market Snippet, By Application
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Increasing collaborations by key market players
    • Lack of awareness regarding healthcare, diet, and proper nutrition
    • Emergence of enhanced parenteral nutrition solutions
  • Key Highlights
  • Regulatory Scenario
  • Market Trends
  • Product Launch/Approval
  • PEST Analysis
  • PORTER's Analysis
  • Epidemiology
  • New Investments by Major Market Players
  • Pricing Analysis
  • Mergers, Acquisitions, and Collaborations

4. Global Parenteral Nutrition Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Parenteral Nutrition Market, By Nutrition Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Carbohydrates
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Lipid Emulsion
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Vitamins and Trace Minerals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Others (Amino acids, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)

6. Global Parenteral Nutrition Market, By Patient Type, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Infants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)

7. Global Parenteral Nutrition Market, By Application, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Diabetes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Renal Failures
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Sarcopenia
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Others (Digestive disorders, Metabolic Syndromes, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)

8. Global Parenteral Nutrition Market, By Distribution Channel, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (US$ Mn)

9. Global Parenteral Nutrition Market, By Region, 2019-2031, (US$ Mn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020 -2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031, (US$ Mn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Nutrition Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Patient Type, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2019-2031, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Danone
    • Fresenius Kabi AG
    • GENTAG, Inc.
    • GSK plc.
    • Nestle SA
    • Nutricia
    • Sun Pharmaceutical Industries Ltd.
    • Pfizer Inc.
    • Sanofi
    • VIRIDIAN SA
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us